Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 3, 2008, Pages 209-212

  Greven, Kathryn M ^a   White, Douglas R ^a   Browne, J Dale ^a   Williams, Daniel W ^a   McGuirt, W Fred ^a   D'Agostino, Ralph B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoradiation; Oropharynx cancer; Radiation therapy; Sequelae; Swallowing dysfunction

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLAVICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STOMACH TUBE; ADJUVANT CHEMOTHERAPY; CANCER STAGING; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PATHOLOGY; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PACLITAXEL; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 44949087745     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181595b10     Document Type: Article

References (16)

1. Bensadoun RJ, Bénézery K, Dassonville O, et al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pha-ryngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys. 2006;64:983-994.
2. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91: 2081-2086.
3. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
4. SAS Version 9.1. Copyright (c) 2002-2003 by SAS Institute, Inc., Cary, NC.
5. Hosmer D Jr, Lemeshow S. Applied Survival Analysis. Hoboken, NJ: John Wiley & Sons; 1999.
6. Forastiere AA, Trotti A. Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyn-geal cancer. J Natl Cancer Inst. 1999;91:2065-2066.
7. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol. 2006;29:32-39.
8. Mendenhall WM, Morris CG, Amdur RJ, et al. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25:535-542.
9. Horiot JC, Fur RL, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992;24:231-241.
10. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol. 2006;29:290- 297.
11. Shiley SG, Hargunani CA, Skoner JM, et al. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg. 2006;134:455-459.
12. Garden AS, Harris J, Vokes EE, et al. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol. 2004;22:2856-2864.
13. Eisbruch A, Schwartz M, Rasch C. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60:1425-1439.
14. Eisbruch A, Lyden T, Bradford CR. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23-28.
15. Logemann JA, Rademaker AW, Pauloski BR. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck. 2006; 28:64-73.
16. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24:2636-2643.